Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Hamburg FDA May Look Favorably On Anti-infectives For Serious Conditions

Sep 21 2009

• By The Pink Sheet

Related Content

Commissioner Margaret Hamburg: Moving FDA Beyond A Regulatory Agency

Jul 06 2009

FDA Updating Antibiotic Guidances, But Is It Too Late For Some Sponsors?

Feb 09 2009

Theravance Gets To Market With Vibativ, But HAP Indication Could Be Pushed To 2010

Sep 14 2009

CAP Drugs Must Meet Stricter Noninferiority Criteria Under Draft FDA Guidance

Jun 08 2009

Getting the Bugs Out of Antibiotic R&D: Commercial Implications of a Higher Regulatory Hurdle

Jun 01 2007

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window